The expression of EMCN and USHBP1 was not statistically significant in the HCC patients compared to the controls from the GSE25097 dataset, but the expression of ANGPT2, GLDN and ZNF532 was significantly higher than the controls. This evidence concerns the gene ANGPT2 and hepatocellular carcinoma.